Companies that reported the most in general payments in 2024

Download CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.

• BioNTech SE 5.3% of the year $180,574,537 · 179 payments
• AbbVie, Inc. 4.6% of the year $156,729,107 · 1,721,235 payments
• Stryker Corporation 3.9% of the year $134,704,915 · 168,381 payments
• Medtronic, Inc. 3.4% of the year $117,697,731 · 342,681 payments
• Arthrex, Inc. 3.1% of the year $104,313,028 · 49,842 payments
• DePuy Synthes Products, Inc. 3% of the year $101,396,521 · 2,547 payments
• Edge Endo LLC 2.7% of the year $91,139,127 · 11 payments
• Zimmer Biomet Holdings, Inc. 2.5% of the year $83,904,351 · 32,760 payments
• Intuitive Surgical, Inc. 2.2% of the year $74,195,093 · 126,596 payments
• Takeda Pharmaceuticals U.S.A., Inc. 2.1% of the year $72,798,432 · 172,052 payments
• AstraZeneca Pharmaceuticals LP 1.9% of the year $64,724,187 · 614,064 payments
• Advanced Accelerator Applications 1.9% of the year $63,931,988 · 167 payments
• Boston Scientific Corporation 1.8% of the year $61,770,892 · 271,484 payments
• Genentech, Inc. 1.7% of the year $59,375,035 · 2,544 payments
• Genzyme Corporation 1.7% of the year $57,615,505 · 182,526 payments
• Lilly USA, LLC 1.4% of the year $46,625,044 · 544,473 payments
• Smith+Nephew, Inc. 1.4% of the year $46,381,798 · 71,450 payments
• Amgen Inc. 1.3% of the year $44,921,708 · 474,864 payments
• Pfizer Inc. 1.3% of the year $43,510,452 · 570,295 payments
• Gilead Sciences, Inc. 1.2% of the year $39,607,599 · 118,932 payments
• Abbott Laboratories 1.1% of the year $38,295,145 · 292,558 payments
• E.R. Squibb & Sons, L.L.C. 0.9% of the year $31,001,339 · 236,558 payments
• Janssen Biotech, Inc. 0.9% of the year $30,912,538 · 298,174 payments
• Edwards Lifesciences Corporation 0.8% of the year $27,843,958 · 70,076 payments
• Henry Schein, Inc. 0.8% of the year $27,412,188 · 2,792 payments
• Globus Medical, Inc. 0.8% of the year $27,038,806 · 23,188 payments
• GlaxoSmithKline, LLC. 0.8% of the year $26,443,627 · 341,439 payments
• Novo Nordisk Inc 0.7% of the year $25,466,536 · 495,369 payments
• Regeneron Healthcare Solutions, Inc. 0.7% of the year $24,733,957 · 169,362 payments
• Medical Device Business Services, Inc. 0.7% of the year $24,422,544 · 32,296 payments
• Merck Sharp & Dohme Corporation 0.7% of the year $23,231,676 · 216,602 payments
• Alphatec Spine, Inc 0.7% of the year $22,334,493 · 6,836 payments
• Encore Medical, LP 0.6% of the year $19,813,424 · 4,691 payments
• LivaNova USA, Inc. 0.6% of the year $19,722,393 · 8,622 payments
• Novartis Pharmaceuticals Corporation 0.6% of the year $19,710,992 · 411,238 payments
• UCB, Inc. 0.5% of the year $18,398,695 · 154,022 payments
• CSL Plasma Inc. 0.5% of the year $17,902,115 · 12,905 payments
• Boehringer Ingelheim Pharmaceuticals, Inc. 0.5% of the year $17,859,513 · 202,521 payments
• AngioDynamics, Inc. 0.5% of the year $17,268,173 · 12,056 payments
• Align Technology, Inc. 0.5% of the year $16,798,811 · 55,540 payments
• Galderma Laboratories, L.P. 0.5% of the year $16,473,758 · 59,761 payments
• Janssen Pharmaceuticals, Inc 0.5% of the year $16,109,202 · 169,360 payments
• AstraZeneca UK Limited 0.5% of the year $15,422,943 · 2,356 payments
• Otsuka America Pharmaceutical, Inc. 0.4% of the year $14,521,670 · 186,436 payments
• Bausch & Lomb Americas Inc. 0.4% of the year $14,412,437 · 89,341 payments
• Neurocrine Biosciences, Inc. 0.4% of the year $14,217,673 · 100,133 payments
• Teva Pharmaceuticals USA, Inc. 0.4% of the year $13,893,192 · 141,158 payments
• Alcon Vision LLC 0.4% of the year $13,360,224 · 94,278 payments
• Siemens Medical Solutions USA, Inc. 0.4% of the year $13,269,907 · 10,318 payments
• Incyte Corporation 0.4% of the year $13,103,674 · 77,737 payments